Long-Acting Antiretroviral Therapies vs. Conventional Oral Regimens in HIV: A Systematic Review

dc.contributor.authorCalderon Chacon, Janinne
dc.contributor.authorGaray Borcosque, Andres M.
dc.contributor.authorLijeron Viana de Araujo, Luccas
dc.date.accessioned2025-05-19T13:03:39Z
dc.date.issued2024
dc.description.abstractBackground: Long-acting antiretroviral therapies (ARV-LA) have emerged as an alternative to daily oral regimens for the management of HIV. This systematic review evaluates the efficacy, safety, and patient satisfaction of ARV-LA, particularly focusing on cabotegravir (CAB-LA) and rilpivirine (RPV-LA), in comparison to standard oral antiretroviral therapies (ART).
dc.identifier.urihttps://repositorio.ucb.edu.bo/handle/20.500.12771/1176
dc.language.isoen
dc.subjectHIV
dc.subjectLong-Acting Antiretroviral Therapy
dc.subjectCabotegravir
dc.subjectRilpivirine
dc.subjectViral Suppression
dc.subjectSafety
dc.titleLong-Acting Antiretroviral Therapies vs. Conventional Oral Regimens in HIV: A Systematic Review
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Long-Acting Antiretroviral Therapies vs. Conventional Oral Regimens in HIV A Systematic Review.pdf
Size:
199.84 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: